Clinical and demographic factors affecting trough levels of isavuconazole in critically ill patients with or without COVID‐19
Ralph Bertram, Rainer Höhl(Nuremberg Hospital), Martina Kinzig(Institute for Biomedical and Pharmaceutical Research), Joerg Steinmann(Essen University Hospital), Matthias Baumgärtel(Nuremberg Hospital), Dorothea Muschner(Nuremberg Hospital), Stefan John(Nuremberg Hospital), Jens Nentwich(Nuremberg Hospital), Golo‐Sung Haarmeyer(Nuremberg Hospital), Vanessa Bartsch(Paracelsus Medical University), Arnim Geise(Nuremberg Hospital), Wolfgang Hitzl(Paracelsus Medical University), Fritz Sörgel(West German Heart and Vascular Center Essen), Hans‐Theodor Naumann(Nuremberg Hospital)
Cited by 19
Related Papers
Proposed nomenclature for Pseudallescheria, Scedosporium and related genera
|Fungal Diversity|2014|181
Elevated Serum Cyclophilin Levels in Patients with Severe Sepsis
|Journal of Clinical Immunology|1997|98
The Fungal PCR Initiative's evaluation of in-house and commercial Pneumocystis jirovecii qPCR assays: Toward a standard for a diagnostics assay
|Medical Mycology|2019|74
Risk factors for paravalvular leak after transcatheter aortic valve replacement
|Journal of Thoracic and Cardiovascular Surgery|2018|65
Aortic valve calcification as a risk factor for major complications and reduced survival after transcatheter replacement
|Journal of cardiovascular computed tomography|2019|56